Skip to content

Prevalence of Vertebral Fractures in HIV Infected Patients Older Than 50 Years

Prevalence of Vertebral Fractures in HIV Infected Patients Older Than 50 Years: Importance of Bone Mineral Density and Bone Biomarkers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02131571
Acronym
FractaVIH
Enrollment
130
Registered
2014-05-06
Start date
2014-06-30
Completion date
2018-06-15
Last updated
2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vertebral Fractures

Keywords

HIV, bone, fractures, vitamin D, biomarkers

Brief summary

Prospective cohort study to determine the prevalence of vertebral fractures in HIV infected patients older than 50 years.

Detailed description

To determine the prevalence of asymptomatic vertebral fractures in HIV patients older than 50 years, and the risk of fracture during a follow up of 2 years, according to bone mineral density at inclusion, the level of serum bone biomarkers, and the presence of secondary factors such as hypovitaminosis D or/and secondary hyperparathyroidism.

Interventions

None listed

Sponsors

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age above 50 years * HIV infection

Exclusion criteria

* Pregnancy * Receiving corticosteroids or antiresorptive therapy

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of vertebral fractures in HIV patients older than 50 years2 yearsTo determine by lumbar and thoracic x ray the presence of vertebral fractures and the changes in vertebral form or size, according to Genant methods

Secondary

MeasureTime frameDescription
Risk of vertebral alteration according to bone mineral density and serum biomarkers2 yearsTo determine the relationships of vertebral alterations with bone mineral density by dual X-ray absorptiometry
Vertebral alterations during follow up2 yearsTo determine the emergence of vertebral alterations during 2 years of follow up according to bone mineral density, bone biomarkers (osteocalcin, beta-crosslaps), and vitamin D/parathyroid hormone (PTH) status.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026